SynapCyte was featured in Centennial Health Special Edition 2018 Single Issue ALZHEIMER'S - NEW HOPE FOR A CURE

SynapCyte and its lead scientific officer, Dr. Kiminobu Sugaya were featured in the article “A FUTURE WITHOUT AD”. The article highlighted Dr. Sugaya’s development of APC-100 as a potential therapy for treating AD and the promising results from his study using AD model mice.